Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138873293> ?p ?o ?g. }
- W2138873293 endingPage "68" @default.
- W2138873293 startingPage "60" @default.
- W2138873293 abstract "Human aldo-keto reductases (AKRs) regulate nuclear receptors by controlling ligand availability. Enzymes implicated in regulating ligand occupancy and trans-activation of the nuclear receptors belong to the AKR1C family (AKR1C1-AKR1C3). Nuclear receptors regulated by AKR1C members include the steroid hormone receptors (androgen, estrogen, and progesterone receptors) and the orphan peroxisome proliferator-activated receptor (PPARgamma). In human myeloid leukemia (HL-60) cells, ligand access to PPARgamma is regulated by AKR1C3, which diverts PGD(2) metabolism away from J-series prostanoids (Desmond et al., 2003). Inhibition of AKR1C3 by indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), caused PPARgamma-mediated terminal differentiation of the HL-60 cells. To discriminate between antineoplastic effects of NSAIDs that are mediated by either AKR1C or cyclooxygenase (COX) isozymes, selective inhibitors are required. We report a structural series of N-phenylanthranilic acid derivatives and steroid carboxylates that selectively inhibit recombinant AKR1C isoforms but do not inhibit recombinant COX-1 or COX-2. The inhibition constants, IC(50), K(I) values, and inhibition patterns were determined for the NSAID analogs and steroid carboxylates against AKR1C and COX isozymes. Lead compounds, 4-chloro-N-phenylanthranilic acid and 4-benzoyl-benzoic acid for the N-phenylanthranilic acid analogs and most steroid carboxylates, exhibited IC(50) values that had greater than 500-fold selectivity for AKR1C isozymes compared with COX-1 and COX-2. Crystallographic and molecular modeling studies showed that the carboxylic acid of the inhibitor ligand was tethered by the catalytic Tyr55-OH(2)(+) and explained why A-ring substituted N-phenylanthranilates inhibited only AKR1C enzymes. These compounds can be used to dissect the role of the AKR1C isozymes in neoplastic diseases and may have cancer chemopreventive roles independent of COX inhibition." @default.
- W2138873293 created "2016-06-24" @default.
- W2138873293 creator A5005730106 @default.
- W2138873293 creator A5013939044 @default.
- W2138873293 creator A5019174025 @default.
- W2138873293 creator A5026491149 @default.
- W2138873293 creator A5059737908 @default.
- W2138873293 creator A5061278758 @default.
- W2138873293 date "2004-10-08" @default.
- W2138873293 modified "2023-09-30" @default.
- W2138873293 title "Development of Nonsteroidal Anti-Inflammatory Drug Analogs and Steroid Carboxylates Selective for Human Aldo-Keto Reductase Isoforms: Potential Antineoplastic Agents That Work Independently of Cyclooxygenase Isozymes" @default.
- W2138873293 cites W1972643373 @default.
- W2138873293 cites W1976654542 @default.
- W2138873293 cites W1996785337 @default.
- W2138873293 cites W1998232267 @default.
- W2138873293 cites W1999019867 @default.
- W2138873293 cites W2001657099 @default.
- W2138873293 cites W2009551530 @default.
- W2138873293 cites W2010311152 @default.
- W2138873293 cites W2011441970 @default.
- W2138873293 cites W2028466456 @default.
- W2138873293 cites W2032925662 @default.
- W2138873293 cites W2036299072 @default.
- W2138873293 cites W2036812496 @default.
- W2138873293 cites W2039358393 @default.
- W2138873293 cites W2043408698 @default.
- W2138873293 cites W2045040068 @default.
- W2138873293 cites W2054535723 @default.
- W2138873293 cites W2062949189 @default.
- W2138873293 cites W2074631079 @default.
- W2138873293 cites W2091149475 @default.
- W2138873293 cites W2101605468 @default.
- W2138873293 cites W2105884586 @default.
- W2138873293 cites W2120859709 @default.
- W2138873293 cites W2125072209 @default.
- W2138873293 cites W2130690545 @default.
- W2138873293 cites W2158795471 @default.
- W2138873293 cites W2396439345 @default.
- W2138873293 cites W2488759014 @default.
- W2138873293 cites W4231524022 @default.
- W2138873293 cites W4235684685 @default.
- W2138873293 cites W4246400425 @default.
- W2138873293 cites W4249363016 @default.
- W2138873293 cites W72293034 @default.
- W2138873293 doi "https://doi.org/10.1124/mol.104.006569" @default.
- W2138873293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15475569" @default.
- W2138873293 hasPublicationYear "2004" @default.
- W2138873293 type Work @default.
- W2138873293 sameAs 2138873293 @default.
- W2138873293 citedByCount "114" @default.
- W2138873293 countsByYear W21388732932012 @default.
- W2138873293 countsByYear W21388732932013 @default.
- W2138873293 countsByYear W21388732932014 @default.
- W2138873293 countsByYear W21388732932015 @default.
- W2138873293 countsByYear W21388732932016 @default.
- W2138873293 countsByYear W21388732932017 @default.
- W2138873293 countsByYear W21388732932018 @default.
- W2138873293 countsByYear W21388732932019 @default.
- W2138873293 countsByYear W21388732932020 @default.
- W2138873293 countsByYear W21388732932021 @default.
- W2138873293 countsByYear W21388732932022 @default.
- W2138873293 countsByYear W21388732932023 @default.
- W2138873293 crossrefType "journal-article" @default.
- W2138873293 hasAuthorship W2138873293A5005730106 @default.
- W2138873293 hasAuthorship W2138873293A5013939044 @default.
- W2138873293 hasAuthorship W2138873293A5019174025 @default.
- W2138873293 hasAuthorship W2138873293A5026491149 @default.
- W2138873293 hasAuthorship W2138873293A5059737908 @default.
- W2138873293 hasAuthorship W2138873293A5061278758 @default.
- W2138873293 hasConcept C104317684 @default.
- W2138873293 hasConcept C116569031 @default.
- W2138873293 hasConcept C119795356 @default.
- W2138873293 hasConcept C121608353 @default.
- W2138873293 hasConcept C126322002 @default.
- W2138873293 hasConcept C134651460 @default.
- W2138873293 hasConcept C170493617 @default.
- W2138873293 hasConcept C181199279 @default.
- W2138873293 hasConcept C185592680 @default.
- W2138873293 hasConcept C2777486698 @default.
- W2138873293 hasConcept C2779689624 @default.
- W2138873293 hasConcept C2780902042 @default.
- W2138873293 hasConcept C530470458 @default.
- W2138873293 hasConcept C55493867 @default.
- W2138873293 hasConcept C59493245 @default.
- W2138873293 hasConcept C63932345 @default.
- W2138873293 hasConcept C71240020 @default.
- W2138873293 hasConcept C71315377 @default.
- W2138873293 hasConcept C71924100 @default.
- W2138873293 hasConcept C84606932 @default.
- W2138873293 hasConcept C86339819 @default.
- W2138873293 hasConcept C86803240 @default.
- W2138873293 hasConcept C98274493 @default.
- W2138873293 hasConceptScore W2138873293C104317684 @default.
- W2138873293 hasConceptScore W2138873293C116569031 @default.
- W2138873293 hasConceptScore W2138873293C119795356 @default.
- W2138873293 hasConceptScore W2138873293C121608353 @default.
- W2138873293 hasConceptScore W2138873293C126322002 @default.
- W2138873293 hasConceptScore W2138873293C134651460 @default.